Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A paper in the New England Journal of Medicine, from Prof Raj Thakker’s group (OCDEM), identifies human germline mutations in GNA11, the gene encoding the G-protein subunit alpha 11 protein.

Double immunofluorescent labelling of BCL11A (red) and CD3 (green) proteins in thymus © Permission must be obtained from Alison Banham (alison.banham@ndcls.ox.ac.uk) before use.
Double immunofluorescent labelling of BCL11A (red) and CD3 (green) proteins in thymus

G alpha 11 mutants with loss of function cause familial hypocalciuric hypercalcemia type 2, and Ga11 mutants with gain of function cause a clinical disorder designated as autosomal dominant hypocalcemia type 2. This study demonstrates the pivotal role of G alpha 11 in calcium-sensing receptor-mediated signal transduction and extra-cellular calcium homeostasis in humans.


The full paper is available.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.